Location of a highly conserved neutralizing epitope in the F glycoprotein of human respiratory syncytial virus.
about
Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial VirusThe 5' ends of Thogoto virus (Orthomyxoviridae) mRNAs are homogeneous in both length and sequenceStructural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titersStructure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing AntibodyAnalysis of Human RSV Immunity at the Molecular Level: Learning from the Past and PresentCleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion.Analysis of respiratory syncytial virus preclinical and clinical variants resistant to neutralization by monoclonal antibodies palivizumab and/or motavizumabIn vitro and in vivo fitness of respiratory syncytial virus monoclonal antibody escape mutants.Stability Characterization of a Vaccine Antigen Based on the Respiratory Syncytial Virus Fusion Glycoprotein.Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B.Identification of a variant subgroup A strain of respiratory syncytial virus.Trivalency of a Nanobody Specific for the Human Respiratory Syncytial Virus Fusion Glycoprotein Drastically Enhances Virus Neutralization and Impacts Escape Mutant Selection.Antigenic structure of human respiratory syncytial virus fusion glycoprotein.Neutralization of human respiratory syncytial virus infectivity by antibodies and low-molecular-weight compounds targeted against the fusion glycoprotein.Premature stop codons in the G glycoprotein of human respiratory syncytial viruses resistant to neutralization by monoclonal antibodies.Immunodominant T-cell epitope on the F protein of respiratory syncytial virus recognized by human lymphocytes.Induction of a neutralizing immune response to human respiratory syncytial virus with anti-idiotypic antibodies.Frame shift mutations as a novel mechanism for the generation of neutralization resistant mutants of human respiratory syncytial virus.In vivo selection of respiratory syncytial viruses resistant to palivizumab.
P2860
Q27333522-4D537EBC-E7E8-4042-8166-234611279494Q27480765-AFC2F3CB-5BC0-4FDA-BE3E-03ECCA0BD0D0Q27667876-0CBEE09C-BB2F-4FF5-8B08-1C19B9DB6654Q27677570-E5C4CEA8-A4E8-4F9A-AD47-40FE9FD7C0E6Q28080556-9A5B652D-919E-426A-A8B7-0169F8A57F75Q33934074-42B92325-4805-42DE-A68A-9118B91B4224Q34772752-D35DCD19-537E-40A4-AD32-5874FB3FCF08Q35140093-21C6A29F-5B4C-4364-8D1F-912EF624EAEDQ36169170-F8E10450-5F31-49A0-93B2-2F5452E08A4DQ36348462-F5BB5E8C-8A21-4553-AE37-EF10B7FAB069Q36540051-C9A2FC96-678C-4AC4-801B-C3F6E47757BBQ38750689-30A626F3-FB9C-40CD-AA66-E06FF4D859B9Q39579940-58912350-5C0C-42C8-994F-467F8EB96983Q39695161-CAA0DB5B-7E30-4CFC-91CB-A14A416C7F29Q40065065-4A4FE01C-26F0-4314-9ACD-2D34C8D329C7Q40067229-BE3F2188-7513-4004-A0A4-168BFFC62735Q40101115-0F5CC9FA-DADF-43EF-809A-8EB71F9B2485Q41235315-0C3C754B-9FAA-4987-BF94-4BA447C663D7Q41891744-EAE82262-C79E-4BB7-995F-B5B793A11BF1
P2860
Location of a highly conserved neutralizing epitope in the F glycoprotein of human respiratory syncytial virus.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Location of a highly conserved ...... n respiratory syncytial virus.
@en
type
label
Location of a highly conserved ...... n respiratory syncytial virus.
@en
prefLabel
Location of a highly conserved ...... n respiratory syncytial virus.
@en
P2093
P2860
P1433
P1476
Location of a highly conserved ...... n respiratory syncytial virus.
@en
P2093
García-Barreno B
P2860
P304
P407
P577
1990-02-01T00:00:00Z